AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Exploring Combination Treatments and Ongoing Trials in MPNs
Exploring Momolotnib and Pachrytneb as potential treatments, highlighting the importance of combination therapies with beta inhibitors and the necessity for further clinical data and licensing decisions. The chapter also touches on ongoing UK trials involving jack inhibitors and long-acting interferons to potentially alter the course of the disease.